Corbus Pharmaceuticals Holdings (CRBP) Profit After Tax (2013 - 2025)

Corbus Pharmaceuticals Holdings' Profit After Tax history runs 13 years deep, the most recent figure standing at -$23.3 million for Q3 2025.

• In Q3 2025, Profit After Tax fell 69.35% year-over-year to -$23.3 million; the TTM figure through Sep 2025 stood at -$67.5 million (down 74.45% YoY), while the FY2024 annual figure was -$40.2 million, up 9.85% from the prior year.
• Profit After Tax was -$23.3 million for Q3 2025 at Corbus Pharmaceuticals Holdings, down from -$17.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$2.2 million in Q3 2021 to a low of -$23.3 million in Q3 2025.
• Historically, Profit After Tax has averaged -$12.1 million across 5 years, with a median of -$10.3 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Profit After Tax soared 93.76% in 2021, then tumbled 303.54% in 2022.
• A 5-year view of Profit After Tax shows it stood at -$10.3 million in 2021, then slipped by 6.03% to -$10.9 million in 2022, then gained by 26.26% to -$8.0 million in 2023, then slipped by 18.8% to -$9.5 million in 2024, then sank by 144.93% to -$23.3 million in 2025.
• The last three Profit After Tax figures came in at -$23.3 million (Q3 2025), -$17.7 million (Q2 2025), and -$17.0 million (Q1 2025), per Business Quant data.